MedPath

Anxiety Sensitivity Program for Smoking Cessation

Not Applicable
Completed
Conditions
Smoking Cessation
Interventions
Behavioral: Anxiety Sensitivity Program for Smoking Cessation
Registration Number
NCT00387049
Lead Sponsor
University of Vermont
Brief Summary

The purpose of this study is to develop and test a smoking cessation intervention for persons who are specifically sensitive to anxiety and anxiety-related bodily sensations.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  1. Aged between 18 and 65 years old
  2. Not pregnant
  3. Regular smoker averaging 10 or more cigarettes per day for at least one year
  4. Score of 25 or greater on 16-item Anxiety Sensitivity Index
  5. Motivation to Quit score of 7 or greater (using Readiness to Quit Ladder)
  6. Not currently using pharmacotherapy for smoking cessation (e.g., Zyban)
  7. No use of other tobacco products (e.g., chewing tobacco, cigars)
  8. No Axis-I or Axis-II diagnoses other than mood or anxiety disorders (intake interview required)
  9. No suicidal or homicidal ideation
  10. No current psychotropic medication use
  11. No evidence of substance abuse or dependence (other than nicotine dependence)
  12. No history of significant medical conditions (cardiovascular, neurological, etc.)
  13. Ability to provide informed, written consent (no evidence of limited mental capacity)
  14. Sufficient command of the English language (able to carry on interview conversation)
  15. Plan to stay in Burlington VT area for at least next 6 months
Read More
Exclusion Criteria
  1. Not between 18-65 years old
  2. Pregnant or currently trying to become pregnant
  3. Regular smoker for less than one year OR smoke less than 10 cigarettes per day
  4. ASI below cutoff level of 25
  5. Motivation to Quit score of 6 or less (using Readiness to Quit Ladder)
  6. Current or recent use of any pharmacotherapy for smoking cessation (e.g., patch, Zyban)
  7. Current use of other tobacco products (e.g., chewing tobacco, cigars)
  8. Axis-I disorders other than anxiety or mood disorders.
  9. Endorsement of suicidality or homicidal ideation.
  10. Any current psychotropic medication use (must have stopped at least 1 month prior).
  11. Any evidence of substance abuse or dependence (other than nicotine dependence)
  12. Any history of significant medical conditions (cardiovascular, neurological, etc.)
  13. Inability to provide informed, written consent (evidence of limited mental capacity)
  14. Insufficient command of the English language (unable to carry on conversation)
  15. Plan to permanently leave Burlington area anytime during the next 6-12 months
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Anxiety-specific smoking cessation careAnxiety Sensitivity Program for Smoking Cessation-
Standard smoking cessation careAnxiety Sensitivity Program for Smoking Cessation-
Primary Outcome Measures
NameTimeMethod
Smoking status24 weeks post Quit Day
Secondary Outcome Measures
NameTimeMethod
Where applicable, length of time from Quit Day to relapse.Determined at conclusion of study

Trial Locations

Locations (1)

University of Vermont

🇺🇸

Burlington, Vermont, United States

© Copyright 2025. All Rights Reserved by MedPath